Production of analogues via Biological C-H activation: Spring 2015 newsletter

Hypha can produce an array of analogues from lead compounds using our talented microbial panels.

The Spring 2015 newsletter highlights a project completed for a client, which exemplifies the production of an array of oxidized analogues obtained from biological C-H activation of the drug ruxolitinib.

Please click here for the newsletter